Cognex Corporation $CGNX Shares Acquired by Mackenzie Financial Corp

Mackenzie Financial Corp increased its stake in shares of Cognex Corporation (NASDAQ:CGNX) by 0.1% during the second quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 4,613,292 shares of the scientific and technical instruments company’s stock after buying an additional 3,490 shares during the quarter. Mackenzie Financial Corp owned about 2.75% of Cognex worth $146,334,000 at the end of the most recent quarter.

Several other institutional investors have also recently added to or reduced their stakes in CGNX. Cetera Investment Advisers lifted its position in Cognex by 36.3% during the 1st quarter. Cetera Investment Advisers now owns 12,288 shares of the scientific and technical instruments company’s stock worth $367,000 after acquiring an additional 3,270 shares during the period. Bayforest Capital Ltd purchased a new stake in shares of Cognex during the first quarter worth approximately $227,000. Kazazian Asset Management LLC raised its stake in shares of Cognex by 9.7% during the first quarter. Kazazian Asset Management LLC now owns 22,564 shares of the scientific and technical instruments company’s stock worth $673,000 after purchasing an additional 2,000 shares during the last quarter. Manchester Capital Management LLC lifted its holdings in shares of Cognex by 41.0% during the first quarter. Manchester Capital Management LLC now owns 2,750 shares of the scientific and technical instruments company’s stock worth $82,000 after purchasing an additional 800 shares during the period. Finally, Blair William & Co. IL grew its position in Cognex by 11.0% in the 1st quarter. Blair William & Co. IL now owns 21,180 shares of the scientific and technical instruments company’s stock valued at $632,000 after buying an additional 2,107 shares during the last quarter. Institutional investors and hedge funds own 88.12% of the company’s stock.

Insider Activity

In other Cognex news, EVP Sheila Marie Dipalma sold 2,002 shares of the firm’s stock in a transaction dated Friday, September 5th. The shares were sold at an average price of $45.00, for a total transaction of $90,090.00. Following the completion of the transaction, the executive vice president directly owned 8,582 shares in the company, valued at approximately $386,190. This trade represents a 18.92% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Robert Willett sold 6,704 shares of Cognex stock in a transaction dated Tuesday, October 21st. The stock was sold at an average price of $49.51, for a total transaction of $331,915.04. The disclosure for this sale is available in the SEC filing. Insiders have sold a total of 10,706 shares of company stock valued at $512,065 over the last 90 days. 1.60% of the stock is currently owned by insiders.

Cognex Price Performance

CGNX opened at $38.21 on Friday. Cognex Corporation has a 1-year low of $22.67 and a 1-year high of $49.76. The stock has a market cap of $6.40 billion, a P/E ratio of 59.70 and a beta of 1.52. The stock’s 50 day simple moving average is $42.70 and its 200 day simple moving average is $38.60.

Cognex (NASDAQ:CGNX) last issued its quarterly earnings data on Wednesday, October 29th. The scientific and technical instruments company reported $0.33 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.27 by $0.06. The firm had revenue of $264.00 million during the quarter, compared to analysts’ expectations of $261.86 million. Cognex had a return on equity of 8.26% and a net margin of 11.33%.Cognex’s revenue was up 18.0% on a year-over-year basis. During the same period in the previous year, the firm posted $0.20 earnings per share. Cognex has set its Q4 2025 guidance at 0.190-0.24 EPS. Research analysts expect that Cognex Corporation will post 0.61 EPS for the current fiscal year.

Cognex Increases Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, November 28th. Investors of record on Thursday, November 13th were paid a $0.085 dividend. This represents a $0.34 dividend on an annualized basis and a yield of 0.9%. The ex-dividend date of this dividend was Thursday, November 13th. This is a positive change from Cognex’s previous quarterly dividend of $0.08. Cognex’s dividend payout ratio is currently 53.13%.

Wall Street Analysts Forecast Growth

A number of brokerages have commented on CGNX. DA Davidson set a $38.00 price objective on shares of Cognex and gave the stock a “neutral” rating in a research report on Monday, November 3rd. The Goldman Sachs Group boosted their price target on shares of Cognex from $36.00 to $40.00 and gave the stock a “sell” rating in a research note on Tuesday, September 16th. Barclays restated an “overweight” rating and issued a $56.00 price objective (up previously from $55.00) on shares of Cognex in a research report on Friday, October 31st. Weiss Ratings reiterated a “hold (c)” rating on shares of Cognex in a research report on Tuesday. Finally, Truist Financial set a $45.00 target price on Cognex and gave the stock a “hold” rating in a research note on Wednesday, October 8th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, eight have given a Hold rating and one has issued a Sell rating to the company. According to data from MarketBeat, Cognex currently has an average rating of “Moderate Buy” and an average target price of $46.20.

Cognex Profile

Cognex Corporation provides machine vision products that capture and analyze visual information to automate manufacturing and distribution tasks worldwide. Its machine vision products are used to automate the manufacturing and tracking of discrete items, including mobile phones, electric vehicle batteries, and e-commerce packages by locating, identifying, inspecting, and measuring them during the manufacturing or distribution process.